Treating Alzheimer Disease With Antiamyloid Therapies—The Real-World Experience Grows

This Medical News article discusses the safety and effectiveness of lecanemab and donanemab in treating mild cognitive impairment and early Alzheimer disease outside clinical trials.

Authors

Publication Details

Journal
JAMA
Published
2025-08-22
DOI
https://doi.org/10.1001/jama.2025.14180
Citations
3
Primary Topic
Cholinesterase and Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
4.18
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treating Alzheimer Disease With Antiamyloid Therapies—The Real-World Experience Grows

Rita Rubin
3 citations
JAMA
Cholinesterase and Neurodegenerative Diseases
4.18
article

Treating Alzheimer Disease With Antiamyloid Therapies—The Real-World Experience Grows

Rita Rubin
article en
3 citations

Abstract

This Medical News article discusses the safety and effectiveness of lecanemab and donanemab in treating mild cognitive impairment and early Alzheimer disease outside clinical trials.

JAMAVol. 334(12)
Openalex Percentile: Top 6%
Cholinesterase and Neurodegenerative Diseases
4.18
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Treating Alzheimer Disease With Antiamyloid Therapies—The Real-World Experience Grows — Rita Rubin · JAMA (2025) | TGRS Research Map | TGRS